Abstract
Chronic kidney disease is common in elderly and frail people. The importance of age in staging chronic kidney disease is discussed as well as the possible constraints of staging what is actually a 'continuum' of disease progression. Frailty is a biological state characterized by the decline of several physiological systems and strongly correlated with adverse health outcomes, including mortality. Frailty is measured by the Comprehensive Geriatric Assessment, which focuses on quantitative rating scales that determine not only the clinical profile and pathological risk of frail individuals, but also their residual capacities, functional status, and quality of life. There is circumstantial evidence that Comprehensive Geriatric Assessment can improve both survival and quality of life in elderly chronic kidney disease patients. Despite the long list of emerging risk factors and markers of chronic kidney disease progression, it is the authors' opinion that a single biochemical parameter can hardly cover the complexity of chronic kidney disease in elderly and frail patients. Among the numerous clinical scores proposed, the European Renal Best Practice guidelines recommend the Renal Epidemiology and Information Network score and the Kidney Failure Risk Equations. The former provides a reasonable estimate of short-term mortality risk, the latter provides the risk of chronic kidney disease progression. In conclusion, the elderly individual with advanced chronic kidney disease is often comorbid and frail with peculiarities in terms of disease grading, clinical assessment and monitoring. The time has come to reshape the care of this growing number of patients by focusing on multidisciplinary teams both in the hospital and in the community.
Notes
This note aims to provide details on the references present in this contribution: they have been divided into two lists due to editorial constraints: the main one, including the most relevant references, according to the evaluation of the authors, is shown in the reference list following the text and denoted as [n]; the supplementary one, inclusive of the other references, is reported as Supplementary Material and indicated as [Sn].
References
Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M (2006) Reviewing the definition of “elderly.” Geriatr Gerontol Int 6(3):149–158
De Lepeleire J, Hiffe S, Mann E, Degryse JM (2009) Frailty: an emerging concept for general practice. Br J Gen Pract 59:e177-182. https://doi.org/10.3399/bjgp09X420653
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K (2013) Frailty in elderly people. Lancet 381:752–762. https://doi.org/10.1016/S0140-6736(12)62167-9
GBD Chronic Kidney Disease Collaboration (2020) Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395:709–733. https://doi.org/10.1016/S0140-6736(20)30045-3
Stenvinkel P, Larsson TE (2013) Chronic kidney disease: a clinical model of premature aging. Am J Kidney Dis 62:339–351. https://doi.org/10.1053/j.ajkd.2012.11.051
Farrington K, Covic A, Nistor I et al (2017) Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 ml/min/1.73 m2): a summary document from the European Renal Best Practice Group. Nephrol Dial Transpl 32:9–16
Corsonello A, Pedone C, Bandinelli S, Ferrucci L, Antonelli IR (2017) Agreement between CKD-EPI and BIS equations for estimating glomerular filtration rate in older people: the InChianti study. Geriatr Gerontol Int 17:1559–1567. https://doi.org/10.1111/ggi.12932
Glassock RJ, Delanaye P, Rule AD (2020) Should the definition of CKD be changed to include age-adapted GFR criteria? YES Kidney Int 97:34–37. https://doi.org/10.1016/j.kint.2019.08.033
Glassock R, Delanaye P, El Nahas M (2015) An age-calibrated classification of chronic kidney disease. JAMA 314:559–560
Levey AS, Inker LA, Coresh J (2020) Should the definition of CKD be changed to include age-adapted GFR criteria? Con: the evaluation and management of CKD, not the definition, should be age-adapted. Kidney Int 97:37–40. https://doi.org/10.1016/j.kint.2019.08.032
Pizzarelli F, Lauretani F, Bandinelli S, Windham GB, Corsi AM, Giannelli SV, Ferrucci L, Guralnik GM (2009) Predictivity of survival according to different equations for estimating renal function in community-dwelling elderly subjects. Nephrol Dial Transpl 24:1197–1205. https://doi.org/10.1093/ndt/gfn594
Fu EL, Coresh J, Grams ME, Clase CM, Elinder CG, Paik J, Ramspek CL, Inker LA, Levey AS, Dekker FW, Carrero JJ (2023) Removing race from the CKD-EPI equation and its impact on prognosis in a predominantly White European population. Nephrol Dial Transpl 38:119–128. https://doi.org/10.1093/ndt/gfac197
Delanaye P, Vidal-Petiot E, Björk J, Ebert N, Eriksen BO, Dubourg L et al (2023) Performance of creatinine-based equations to estimate glomerular filtration rate inWhite and Black populations in Europe, Brazil and Africa. Nephrol Dial Transpl 38:106–118. https://doi.org/10.1093/ndt/gfac241
Gansevoort RT, Anders HJ, Cozzolino M, Fliser D, Fouque D, Ortiz A, Soler MJ, Wanner C (2023) What should European nephrology do with the new CKD-EPI equation? Nephrol Dial Transpl 38:1–6. https://doi.org/10.1093/ndt/gfac254
Couser WG (2007) Chronic kidney disease-the promise and the perils. J Am Soc Nephrol 18:2803–2805
Couchoud CG, Beuscart JB, Aldigier JC, Brunet PJ, Moranne OP, Registry REIN (2015) Development of a risk stratification algorithm to improve patient-centered care and decision makingfor incident elderly patients with end-stage renal disease. Kidney Int 88:1178–1186. https://doi.org/10.1038/ki.2015.245
Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS (2011) A predictive model for progression of chronic kidney disease to kidney failure. JAMA 305:1553–1559. https://doi.org/10.1001/jama.2011.451
Pugh J, Aggett J, Goodland A, Prichard A, Thomas N, Donovan K, Roberts G (2016) Frailty and comorbidity are independent predictors of in patients referred for pre-dialysis education. Clin Kidney J 9:324–329. https://doi.org/10.1093/ckj/sfv150
Kennard A, Glasgow S, Rainsford S, Talaulikar G (2022) Frailty in chronic kidney disease: challenges in nephrology practice. A review of current literature. Intern Med J. https://doi.org/10.1111/imj.15759
Puthumana J, Thiessen-Philbrook H, Xu L, Coca SG, Garg AX, Himmelfarb J, Bhatraju PK, Ikizler TA, Siew ED, Ware LB, Liu KD, Go AS, Kaufman JS, Kimmel PL, Chinchilli VM, Cantley LG, Parikh CR (2021) Biomarkers of inflammation and repair in kidney disease progression. J Clin Invest 131:e139927. https://doi.org/10.1172/JCI139927
Stuck AE, Siu AL, Wieland GD, Adams J, Rubenstein LZ (1993) Comprehensive geriatric assessment: a meta-analysis of controlled trials. Lancet 342:1032–1036. https://doi.org/10.1016/0140-6736(93)92884-v
Ellis G, Gardner M, Tsiachristas A, Langhorne P, Burke O, Harwood RH, Conroy SP, Kircher T, Somme D, Saltvedt I, Wald H, O’Neill D, Robinson D (2017) Shepperd S (2017) Comprehensive geriatric assessment for older adults admitted to hospital. Cochrane Database Syst Rev 9(9):CD006211. https://doi.org/10.1002/14651858.CD006211.pub3
Hall RK, Haines C, Gorbatkin SM, Schlanger L, Shaban H, Schell JO, Gurley SB, Colón-Emeric CS, Bowlinget CB (2016) Incorporating geriatric assessment into a nephrology clinic: preliminary data from two models of care. J Am Geriatr Soc 64:2154–2158. https://doi.org/10.1111/jgs.14262
Hoshino J (2021) Renal rehabilitation: exercise intervention and nutritional support in dialysis patients. Nutrients 13:1444. https://doi.org/10.3390/nu13051444
Whiting P, Morden A, Tomlinson LA, Caskey F, Blakeman T, Tomson C, Stone T, Richards A, Savović J, Horwood J (2017) What are the risks and benefits of temporarily discontinuing medications to prevent acute kidney injury? A systematic review and meta-analysis. BMJ Open 7:e012674. https://doi.org/10.1136/bmjopen-2016-012674
Bhandari S, Mehta S, Khwaja A, Cleland JGF, Ives N, Brettell E, Chadburnand M, Cockwell P, For the STOP ACEi Trial Investigators (2022) Renin-angiotensin system inhibition in advanced chronic kidney disease. N Engl J Med 387:2021–2032. https://doi.org/10.1056/NEJMoa2210639
Dattolo PC, Gallo P, Michelassi S, Paudice N, Cannavò R, Romoli E, Fani TA, Mehmetaj A, Ferro G, Sisca S, Pizzarelli F (2016) Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors. J Nephrol 29:809–815. https://doi.org/10.1007/s40620-016-0290-9
de la Espriella R, Marcos MC, Ronco C, Banerjee D, González M, Górriz JL, Quiroga B, Soler MJ, Díez J, Núñez J (2022) Practical approaches to building up a cardiorenal clinic. Clin Kidney J. https://doi.org/10.1093/ckj/sfac258
Ahmed FA (2018) Kidney disease in elderly: importance of collaboration between geriatrics and nephrology. Ageing and Disease 9:745–747. https://doi.org/10.14336/AD.2018.0223
Chou A, Li KC, Brown MA (2022) Survival of older patients with advanced CKD managed without dialysis: a narrative review. Kidney Med 4:100447. https://doi.org/10.1016/j.xkme.2022.100447
Slinin Y, Greer N, Ishani A, MacDonald R, Olson C, Rutks I, Wilt TJ (2015) Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline. AJKD 66:823–836. https://doi.org/10.1053/j.ajkd.2014.11.031
Fu EL, Evans M, Carrero JJ, Putter H, Clase CM, Caskey FJ, Szymczak M, Torino C, Chesnaye NC, Jager KJ, Wanner C, Dekker FW, van Diepen M (2021) Timing of dialysis initiation to reduce mortality and cardiovascular events in advanced chronic kidney disease: nationwide cohort study. BMJ 375:e066306. https://doi.org/10.1136/bmj-2021-066306
Dattolo P, Michelassi S, Amidone M, Allinovi M, Vignali L, Antognoli G, Roperto R, Pizzarelli F (2015) Structured clinical follow-up for CKD stage 5 may safely postpone dialysis. J Nephrol 28:463–469. https://doi.org/10.1007/s40620-014-0123-7
Acknowledgements
The great contribution of Giuseppe Ferro to the present manuscript is acknowledged.
Funding
No funding agency granted the present study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Data availability
The data underlying this article will be shared on reasonable request to the corresponding author.
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
No verbal and written informed consent was necessary for this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Pizzarelli, F., Basile, C., Aucella, F. et al. Chronic kidney disease in the elderly and frail patient: perspectives with opinions and comments. J Nephrol 36, 1565–1570 (2023). https://doi.org/10.1007/s40620-023-01676-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-023-01676-y